Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02217865 · ClinicalTrials.gov registry record
Patient-Centered Risk Adjusted Surveillance After Curative Resection of Colorectal Cancer
A clinical trial, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- 32
- Enrollment target
NCT02217865: Completed study, sponsored by M.D. Anderson Cancer Center.
NCT02217865 is a clinical trial that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 32 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02217865 has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- 32 participants
- Enrollment target
Study Summary
The long-term goal of this research is to develop new tools to guide patients, caregivers, and clinicians in making individualized decisions regarding colorectal cancer (CRC) surveillance. As part of a Patient-Centered Outcomes Research Institute-funded contract, investigator will analyze surveillance data to determine the effectiveness of CRC surveillance and recurrence risk taking into account different patient and tumor characteristics; identify key issues about CRC surveillance important to patients, caregivers, and clinicians; and integrate the recurrence risk and patient priorities into a patient-centered, risk stratified surveillance strategy by creating an interactive decision aid for use by patients and clinicians. This protocol addresses a formative step in the creation of the interactive decision aid where patients' information needs and preferences are assessed regarding decisions about surveillance. The specific aims of this protocol are: Phase 1 - To interview patients and their caregivers to determine their concerns, preferences and key priorities regarding surveillance after curative resection of colorectal cancer, and Phase 2 - To refine the key priorities identified in phase 1 through focus groups and surveys with patients and caregivers.
Primary Outcome
Semi-structured interviews and focus groups reviewed to identify themes related to participants' and caregiver's priorities regarding surveillance of colorectal cancer.
Interventions
- BEHAVIORAL Questionnaire
- BEHAVIORAL Focus Groups
- BEHAVIORAL Interviews - Colorectal Cancer Participants
- BEHAVIORAL Interviews - Caregivers of Colorectal Cancer Participants
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2014-07-16 |
| Est. Completion | 2022-01-13 |
What the finished NCT02217865 record still lists
NCT02217865 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 32 participants, a relatively small participant target.
The record links to 0 conditions, and to 4 interventions - of which Questionnaire is the first listed.
NCT02217865 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02217865 about?
NCT02217865 is a clinical study titled "Patient-Centered Risk Adjusted Surveillance After Curative Resection of Colorectal Cancer". The long-term goal of this research is to develop new tools to guide patients, caregivers, and clinicians in making individualized decisions regarding colorectal cancer (CRC) surveillance. As part of a Patient-Centered Outcomes Research Institute-funded contract, investigator will analyze surveillan...
What is the current status of trial NCT02217865?
This trial is currently completed. The enrollment target is 32 participants. The study started on 2014-07-16. Estimated completion is 2022-01-13.
What interventions are being tested in trial NCT02217865?
The interventions under investigation include: Questionnaire (BEHAVIORAL), Focus Groups (BEHAVIORAL), Interviews - Colorectal Cancer Participants (BEHAVIORAL), Interviews - Caregivers of Colorectal Cancer Participants (BEHAVIORAL).
Who is sponsoring clinical trial NCT02217865?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02445781 · 32 participants · Early Phase 1
Differing Levels of Hypoglycemia
- NCT02792270 · 32 participants · NA
Caloric Restriction In Sarcoma Patients Treated With Pre-Operative RT
- NCT03068910 · 32 participants · Early Phase 1
Hyperandrogenemia and Altered Day-night LH Pulse Patterns
- NCT03208868 · 32 participants · NA
Leucine Enriched Essential Amino Acid Mixture to Reverse Muscle Loss in Cirrhosis
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI